Condition
Hormone Receptor-positive Metastatic Breast Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hormone Receptor-positive Metastatic Breast Cancer clinical trials that are recruiting, at sites in 3 countries (most in Germany (1), Switzerland (1), Italy (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy
This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.
-
Combining Abemaciclib with Endocrine Therapy for Advanced Breast Cancer
This study is testing if combining a drug called Abemaciclib with other hormone treatments can help women with advanced breast cancer feel better and manage side effects more effectively.
Related topics
Quick answers
How many Hormone Receptor-positive Metastatic Breast Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Germany (1 trial), Switzerland (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.